| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.73▲ | 2.71▲ | 2.71▲ | 2.80▼ | 2.83▼ |
| MA10 | 2.73▲ | 2.71▲ | 2.72▲ | 2.74▲ | 3.15▼ |
| MA20 | 2.71▲ | 2.79▼ | 2.82▼ | 2.89▼ | 2.85▼ |
| MA50 | 2.81▼ | 2.77▼ | 2.74▲ | 3.30▼ | 3.25▼ |
| MA100 | 2.75▲ | 2.77▼ | 2.85▼ | 2.85▼ | 3.98▼ |
| MA200 | 2.78▼ | 2.95▼ | 3.01▼ | 3.05▼ | 3.78▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | -0.007▼ | -0.014▼ | 0.007▲ | -0.007▼ |
| RSI | 52.989▲ | 48.900▼ | 49.080▼ | 41.830▼ | 46.494▼ |
| STOCH | 72.357 | 46.245 | 39.297 | 44.741 | 23.456 |
| WILL %R | -4.348▲ | -21.429▲ | -59.259 | -64.815 | -70.175 |
| CCI | 100.247▲ | 30.805 | -20.785 | -45.749 | -65.157 |
|
Thursday, August 09, 2018 07:05 PM
Anavex Life Sciences Corp (NASDAQ:AVXL) Q3 2018 Earnings Conference Call August 9, 2018 4:30 PM ET Executives Scott Gordon – Investor Relations Christopher Missling – President and Chief Executive Off...
|
|
Thursday, August 09, 2018 01:47 PM
“In order to identify the key biomarkers for the design of our late-stage CNS precision medicine trials, we have taken a data driven, hypothesis free approach to the systematic analysis of our ongoing ...
|
|
Monday, July 30, 2018 01:56 AM
Analysts at Maxim Group viewed clinical trial data presented by Neurotrope Inc (NASDAQ:NTRP) and Anavex Life Sciences Corp (NASDAQ:AVXL) at the Alzheimer`s Association International Conference as an i...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/08/18 | 2.72 | 2.78 | 2.62 | 2.75 | 516,027 |
| 10/08/18 | 2.79 | 2.815 | 2.69 | 2.74 | 311,043 |
| 09/08/18 | 3.01 | 3.06 | 2.75 | 2.83 | 287,672 |
| 08/08/18 | 2.78 | 2.99 | 2.7598 | 2.90 | 336,319 |
| 07/08/18 | 2.73 | 2.80 | 2.68 | 2.78 | 161,591 |
| 06/08/18 | 2.64 | 2.759 | 2.61 | 2.70 | 188,090 |
| 03/08/18 | 2.63 | 2.66 | 2.56 | 2.64 | 219,822 |
| 02/08/18 | 2.68 | 2.685 | 2.5698 | 2.62 | 450,316 |
| 01/08/18 | 2.70 | 2.72 | 2.594 | 2.71 | 424,013 |
| 31/07/18 | 2.88 | 2.899 | 2.70 | 2.70 | 338,189 |
|
|
||||
|
|
||||
|
|
||||
|
|